Clinical outcomes in people with type 2 diabetes and acute kidney disease: combined SGLT2i and GLP-1RA therapy vs
While the FDA does not have a specific GLP-1 friendly claim standard yet, brands are using language like high protein, small portions, nutrient-dense snack, and designed for mindful eating to signal relevance to this consumer segment
When I was on it, the cravings for sugar completely stopped and I had no inflammation
The higher stress on your bones from higher body weight spurs bone formation
Effectiveness depends on individual genetics and lifestyle adherence, not whether the medication is branded or compounded
Response may be affected by starting weight, research dose, medical history, nutrition, physical activity, side effects, treatment duration, and whether the participant remains in the study